A large proportion of patients with congenital heart disease (CHD), in particular those with
relevant systemic-to-pulmonary shunts, will develop pulmonary arterial hypertension (PAH) …

Pulmonary arterial hypertension of variable degree is commonly associated with adult
congenital heart disease. Depending on size and location of the underlying cardiac defect …

Aims This study compared the clinical, functional, and haemodynamic characteristics and
current era survival of subgroups of patients with pulmonary arterial hypertension associated …

Pulmonary arterial hypertension (PAH) is a common complication of congenital heart
disease (CHD), with most cases occurring in patients with congenital cardiac shunts. In …

Pulmonary Arterial Hypertension (PAH) is a recognized complication of congenital cardiac
defects that are characterized by chronic left-to-right shunting. Viktor Eisenmenger initially …

Pulmonary arterial hypertension (PAH) is commonly associated with congenital heart
disease (CHD) and relates to type of the underlying cardiac defects and repair history. Large …

The presence of pulmonary arterial hypertension (PAH) increases morbidity and reduces
survival in patients with congenital heart disease (CHD). PAH-CHD is a heterogeneous …

Pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) is a
complex disease that presents with a broad spectrum of morphological and haemodynamic …

Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension
(PAH) associated with congenital heart disease, is a devastating condition that has a …

The incidence of congenital heart disease is approximately 8/1,000 live births and appears
to be constant around the world. The currently accepted paradigm for the development of …